Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome

Alzheimers Dement. 2023 Nov;19(11):5129-5137. doi: 10.1002/alz.13097. Epub 2023 Apr 28.

Abstract

Introduction: Adults with Down syndrome (DS) are at ultra-high risk of developing Alzheimer's disease (AD), characterized by poor episodic memory and semantic fluency in the preclinical phase in the general population. We explored semantic fluency performance in DS and its relationship to age, AD, and blood biomarkers.

Methods: A total of 302 adults with DS at baseline and 87 at follow-up from the London Down Syndrome Consortium cohort completed neuropsychological assessments. Blood biomarkers were measured with the single molecule array technique in a subset of 94 participants.

Results: Poorer verbal fluency performance was observed as age increases. Number of correct words declined in those with AD compared to those without over 2 years and was negatively correlated with neurofilament light (r = -0.37, P = .001) and glial fibrillary acidic protein (r = -0.31, P = .012).

Discussion: Semantic fluency may be useful as an early indicator of cognitive decline and provide additional information on AD-related change, showing associations with biomarkers in DS.

Keywords: Alzheimer's disease; Down syndrome; animal subcategories; glial fibrillary acidic protein; intrusions; neurofilament light; repetitions; semantic verbal fluency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alzheimer Disease* / epidemiology
  • Biomarkers
  • Down Syndrome* / complications
  • Humans
  • Memory Disorders
  • Neuropsychological Tests
  • Semantics
  • Verbal Behavior

Substances

  • Biomarkers